- $37.50m
- -$136.70m
- $14.78m
- 32
- 43
- 38
- 30
Annual balance sheet for Akso Health, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 15.1 | 18.4 | 7.92 | 85.2 | 176 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 14.4 | 20 | 9.23 | 0 | 12.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 30.1 | 62.8 | 20.5 | 142 | 196 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.067 | — | — | — | 0.115 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 31.7 | 62.8 | 20.5 | 142 | 215 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14.4 | 50.5 | 11.6 | 3.59 | 13.8 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.4 | 50.5 | 11.7 | 3.65 | 15.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 17.3 | 12.3 | 8.73 | 138 | 199 |
| Total Liabilities & Shareholders' Equity | 31.7 | 62.8 | 20.5 | 142 | 215 |